Cefuaxit

Cefuaxit Indications/Uses

cefuroxime

Manufacturer:

Nectar Lifesciences

Distributor:

Royal Distribution

Marketer:

ESTI Pharma
Full Prescribing Info
Indications/Uses
Tablet: Cefuroxime axetil is indicated for the treatment of the infections listed as follows in adults and children from the age of 3 months: Acute streptococcal tonsillitis and pharyngitis; Acute bacterial sinusitis; Acute otitis media; Acute exacerbations of chronic bronchitis; Cystitis; Pyelonephritis; Uncomplicated skin and soft tissue infections; Treatment of early Lyme disease.
Injection: Cefuroxime for Injection USP 750 mg is indicated for the treatment of the infections listed as follows in adults and children, including neonates: Community acquired pneumonia; Acute exacerbations of chronic bronchitis; Complicated urinary tract infections, including pyelonephritis; Soft-tissue infections: cellulitis, erysipelas and wound infections; Intra-abdominal infections; Prophylaxis against infection in gastrointestinal (including oesophageal), Orthopaedic, cardiovascular, and Gynaecological surgery (including caesarean section).
In the treatment and prevention of infections in which it is very likely that anaerobic organisms will be encountered, Cefuroxime should be administered with additional appropriate antibacterial agents.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in